Recent News

• 04.22.2025 - Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
• 04.17.2025 - Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
• 04.15.2025 - New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
• 04.10.2025 - Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
• 04.02.2025 - Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
• 03.28.2025 - Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks
• 03.04.2025 - Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025
• 03.04.2025 - Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
• 03.04.2025 - Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024
• 02.28.2025 - Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center

Recent Filings

• 04.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.20.2025 - 4/A Statement of changes in beneficial ownership of securities
• 03.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.14.2025 - N-CEN Annual Report for Registered Investment Companies
• 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2025 - NPORT-P Monthly Portfolio Investments Report on Form N-PORT (Public)
• 03.03.2025 - N-CSR Certified Shareholder Report